ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Urged To Back Ultrasounds Studies

October 1, 1976

NIH Sets Tuition Cost Policy For NRSA Grants

February 9, 1996

Risk Assessment Key In Long-Term Treatment

August 29, 2008

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975

In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.

April 2, 1999

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981